老年糖尿病合并急性冠状动脉综合征患者介入治疗后造影剂肾病发生的危险因素分析
DOI:
作者:
作者单位:

(1.河北省承德市中心医院肾内科,河北省承德市 067000;2.河北省承德市中心医院心内科,河北省承德市 067000)

作者简介:

王玉慧,硕士,主治医师,主要从事慢性肾脏病、IgA肾病及造影剂肾病方面的研究工作,E-mail为eulogy6687@163.com。

通讯作者:

基金项目:


Influencing factors of contrast-induced nephropathy after percutaneous coronary intervention in elderly diabetic patients with acute coronary syndrome
Author:
Affiliation:

1.Department of Nephrology, ;2.Department of Cardiology, Central Hospital of Chengde, Chengde, Hebei 067000, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨非离子型造影剂对于老年糖尿病合并急性冠状动脉综合征(ACS)患者经皮冠状动脉介入治疗(PCI)后造影剂肾病(CIN)发生的影响,筛选可能的危险因素。方法 选取行PCI治疗的134例老年糖尿病合并ACS患者(年龄≥65岁),选择同期无糖尿病的145例老年PCI患者进行对比,比较两组患者的年龄、术前脑钠尿肽、射血分数、25-羟维生素D、估算的肾小球滤过率(eGFR)、血白蛋白等。应用多因素Logistic回归分析筛查可能的危险因素。结果 134例老年糖尿病PCI患者发生造影剂肾病17例,发生率为12.6%,无糖尿病的145例老年PCI患者发生造影剂肾病13例,发生率8.9%,两组之间比较差异无统计学意义(P>0.05);两组之间性别、围手术期用药中ACEI/ARB比较差异有统计学意义(P<0.05);糖尿病组术前BNP、纤维蛋白原、血小板体积分布宽度高于非糖尿病组,25-羟维生素D低于非糖尿病组(P<0.05)。对老年糖尿病合并ACS患者PCI后发生造影剂肾病行Loistic回归分析显示,纤维蛋白原、25-羟维生素D进入回归方程,为造影剂肾病发生的危险因素,术前纤维蛋白原升高增加造影剂肾病的发病风险(OR=3.403,95%CI:1.353~6.845,P=0.007),25-羟维生素D降低使造影剂肾病发生风险显著增加(OR=0.485,95%CI:0.282~0.833,P=0.009)。结论 术前纤维蛋白原升高、25-羟维生素D下降使老年糖尿病合并ACS患者PCI术后造影剂肾病发生风险增加。

    Abstract:

    Aim To find risk factors of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) in elderly diabetic patients with acute coronary syndrome (ACS). Methods 134 cases of elderly diabetic patients with ACS (≥65 years old) was involved in this study. In the same period, 145 cases of PCI patients without diabetes were used as controls. The age, preoperation brain natriuretic peptide (BNP), ejection fraction, 25 hydroxyvitamin D, estimated glomerular filtration rate (eGFR), blood albumin and so on were compared between the two groups. Multifactor logistic regression analysis was used to find risk factors of CIN. Results 17 cases of CIN were found in 134 cases of patients with diabetes after PCI, the incidence was 12.6%. In 145 elderly patients without diabetes, there were 13 cases of CIN, with an incidence of 8.9%, there was no statistically significant difference between the two groups (P>0.05). Statistically difference was found in gender and perioperative use of ACEI/ARB between two groups (P<0.05). Preoperation BNP, fibrinogen, platelet volume distribution of the diabetes group was higher than non-diabetic, 25 hydroxyvitamin D was lower than non-diabetic group (P<0.05). Loistic regression analysis showed that fibrinogen and 25 hydroxyvitamin D were the risk factors of CIN for elderly diabetic patients with acute coronary syndrome after PCI. Preoperative fibrinogen elevation increased the risk of CIN (OR=3.3,5%CI 1.353~6.845, P=0.007), 25 hydroxyvitamin D reduction increased the risk of CIN (OR=0.5,5%CI 0.282~0.833, P=0.009). Conclusion The risk of CIN was increased when preoperative fibrin was elevated and 25 hydroxyvitamin D was decreased in elderly diabetes mellitus patients with acute coronary syndrome after PCI.

    参考文献
    相似文献
    引证文献
引用本文

王玉慧,董铁铸,宋静莹,王海峰,周江.老年糖尿病合并急性冠状动脉综合征患者介入治疗后造影剂肾病发生的危险因素分析[J].中国动脉硬化杂志,2018,26(4):389~393.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2017-12-06
  • 最后修改日期:2018-03-10
  • 录用日期:
  • 在线发布日期: 2018-05-04